Glen Eagle Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $59.8K | Hold |
557
| – | – | 0.01% | 392 |
|
|
2025
Q1 | $56.2K | Hold |
557
| – | – | 0.01% | 395 |
|
|
2024
Q4 | $49.8K | Sell |
557
-290
| -34% | -$25.9K | 0.01% | 410 |
|
|
2024
Q3 | $71K | Hold |
847
| – | – | 0.01% | 364 |
|
|
2024
Q2 | $65.2K | Buy |
847
+290
| +52% | +$22.3K | 0.01% | 364 |
|
|
2024
Q1 | $38.1K | Hold |
557
| – | – | 0.01% | 454 |
|
|
2023
Q4 | $32.2K | Buy |
557
+90
| +19% | +$5.2K | 0.01% | 458 |
|
|
2023
Q3 | $24.7K | Hold |
467
| – | – | 0.01% | 488 |
|
|
2023
Q2 | $25.3K | Hold |
467
| – | – | 0.01% | 484 |
|
|
2023
Q1 | $23.4K | Buy |
467
+167
| +56% | +$8.36K | 0.01% | 488 |
|
|
2022
Q4 | $13.9K | Hold |
300
| – | – | ﹤0.01% | 550 |
|
|
2022
Q3 | $11.6K | Hold |
300
| – | – | ﹤0.01% | 568 |
|
|
2022
Q2 | $11.2K | Hold |
300
| – | – | ﹤0.01% | 597 |
|
|
2022
Q1 | $13.3K | Hold |
300
| – | – | ﹤0.01% | 574 |
|
|
2021
Q4 | $12.7K | Sell |
300
-5
| -2% | -$212 | ﹤0.01% | 577 |
|
|
2021
Q3 | $13.3K | Hold |
305
| – | – | ﹤0.01% | 642 |
|
|
2021
Q2 | $13K | Hold |
305
| – | – | ﹤0.01% | 642 |
|
|
2021
Q1 | $11.8K | Buy |
305
+5
| +2% | +$193 | ﹤0.01% | 635 |
|
|
2020
Q4 | $10.8K | Hold |
300
| – | – | ﹤0.01% | 621 |
|
|
2020
Q3 | $11.5K | Sell |
300
-93
| -24% | -$3.55K | 0.01% | 572 |
|
|
2020
Q2 | $13.8K | Buy |
393
+93
| +31% | +$3.27K | 0.01% | 506 |
|
|
2020
Q1 | $9.79K | Hold |
300
| – | – | 0.01% | 514 |
|
|
2019
Q4 | $13.6K | Hold |
300
| – | – | 0.01% | 522 |
|
|
2019
Q3 | $12.2K | Sell |
300
-27
| -8% | -$1.1K | 0.01% | 477 |
|
|
2019
Q2 | $14.1K | Hold |
327
| – | – | 0.01% | 451 |
|
|
2019
Q1 | $12.6K | Buy |
327
+27
| +9% | +$1.04K | 0.01% | 447 |
|
|
2018
Q4 | $10.6K | Buy |
+300
| New | +$10.6K | 0.01% | 451 |
|